№ files_lp_4_process_3_106617
Regulatory source detailing FSANZ’s assessment and approval of a genetically modified 2′-fucosyllactose ingredient for use in infant formula, including specifications, safety evaluation, submissions received, and associated compliance conditions.
Year: 2022
Region / Jurisdiction: Australia and New Zealand
Subject: Food standards and safety assessment
Document type: Regulatory approval report
Organization: Food Standards Australia New Zealand (FSANZ)
Applicant: Friesland Campina Ingredients
Target audience: Food industry, regulatory authorities, infant formula manufacturers
Date of submission: 6 December 2021
Date of approval: 6 May 2022
Product: 2′-Fucosyllactose (2′-FL) from GM E. coli K-12
Maximum permitted concentration: 2.4 g/L
Review period: Five-year review to be completed by March 2026
Exclusivity period: 15 months under brand name Aequival® 2′-FL
Specifications: Harmonized with EU standards for 2′-FL
Safety assessment: No safety concerns identified for production organism or 2′-FL product
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.